The store will not work correctly when cookies are disabled.
1-Benzyl-5-oxy-1H-pyrido[2,3-b]quinoxalin-2-ylideneamine
ID: ALA349511
PubChem CID: 44377823
Max Phase: Preclinical
Molecular Formula: C18H14N4O
Molecular Weight: 302.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N=c1ccc2c(nc3ccccc3[n+]2[O-])n1Cc1ccccc1
Standard InChI: InChI=1S/C18H14N4O/c19-17-11-10-16-18(21(17)12-13-6-2-1-3-7-13)20-14-8-4-5-9-15(14)22(16)23/h1-11,19H,12H2
Standard InChI Key: PQVDHJTTYOGOIF-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
4.5417 -3.8167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0667 -4.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0667 -4.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5917 -5.0167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5500 -5.0250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1167 -4.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0292 -4.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5875 -3.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0292 -4.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1042 -4.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 -3.2167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6000 -5.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6375 -5.0042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0792 -5.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5042 -3.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5042 -5.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5625 -5.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0875 -6.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9917 -4.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9917 -4.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5750 -6.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0417 -5.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0500 -6.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 1 2 0
4 2 1 0
5 9 1 0
6 10 1 0
7 1 1 0
8 3 1 0
9 7 1 0
10 8 2 0
11 1 1 0
12 4 1 0
13 6 2 0
14 12 1 0
15 7 2 0
16 9 2 0
17 14 2 0
18 14 1 0
19 15 1 0
20 19 2 0
21 18 2 0
22 17 1 0
23 21 1 0
2 5 2 0
16 20 1 0
6 4 1 0
23 22 2 0
M CHG 2 1 1 11 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 302.34 | Molecular Weight (Monoisotopic): 302.1168 | AlogP: 2.35 | #Rotatable Bonds: 2 |
Polar Surface Area: 68.61 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.06 | CX LogP: 2.46 | CX LogD: 2.46 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.35 | Np Likeness Score: -0.66 |
References
1. Glazer EA, Chappel LR.. (1982) Pyridoquinoxaline N-oxides. 1. A new class of antitrichomonal agents., 25 (7): [PMID:7108893] [10.1021/jm00349a603] |